FibroGen, Inc. is a company in the U.S. stock market and it is a holding in 61 U.S.-traded ETFs. FGEN has around 8.7M shares in the U.S. ETF market. The largest ETF holder of FGEN is the iShares Russell 2000 ETF (IWM), with approximately 1.75M shares. Investors may also find of interest that the ETF with the largest allocation to FGEN stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 4.37%. On average, U.S. ETFs allocate 0.40% of FGEN to their portfolios.
Additionally, FGEN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with FGEN as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.